Pupillary response to percutaneous auricular vagus nerve stimulation in alcohol withdrawal syndrome: A pilot trial
Treiber MC, Grünberger J, Vyssoki B, Szeles JC, Kaniusas E, Kampusch S, Stöhr H, Walter H, Lesch OM, König D, et al.
Alcohol · 2024
Key finding
In patients undergoing alcohol withdrawal, percutaneous auricular VNS enhanced parasympathetic tone, roughly halving tropicamide-induced pupillary dilation in this open-label pilot.
- Condition
- Addiction
- Stimulation
- taVNS
- Evidence tier
- Controlled Clinical Trial
- Participants
- 30
Cite this study
Treiber, M. C., Grünberger, J., Vyssoki, B., Szeles, J. C., Kaniusas, E., Kampusch, S., Stöhr, H., Walter, H., Lesch, O. M., König, D., & Kraus, C. (2024). Pupillary response to percutaneous auricular vagus nerve stimulation in alcohol withdrawal syndrome: A pilot trial. Alcohol, 114, 61-68. https://doi.org/10.1016/j.alcohol.2023.08.009
Related studies in Addiction
Non-invasive brain stimulation modalities for the treatment and prevention of opioid use disorder: a systematic review of the literature
Young et al. · Journal of addictive diseases · 2020 · Systematic Review / Meta-Analysis
Transcutaneous cervical vagus nerve stimulation reduces behavioral and physiological manifestations of withdrawal in patients with opioid use disorder: A double-blind, randomized, sham-controlled pilot study
Gazi et al. · Brain Stimulation · 2022 · Randomised Controlled Trial
Noninvasive vagal nerve stimulation reduces withdrawal-related affective distress and improves functional outcomes in alcohol use disorder - A feasibility and acceptability pilot study
Klaming et al. · Neuromodulation · 2025 · Controlled Clinical Trial
Leveraging Accelerometry as a Prognostic Indicator for Increase in Opioid Withdrawal Symptoms
Lambert et al. · Biosensors · 2022 · Controlled Clinical Trial
Summary by Vagus Research. Always consult the primary source for the authoritative record.